Lance Baldo
Plus aucun poste en cours
Profil
Lance Baldo a fondé MedAptus, Inc. Actuellement, le Dr Baldo est directeur médical d'Adaptive Biotechnologies Corp. Dans le passé, le Dr Baldo a été vice-président principal et chef des affaires médicales américaines chez Genentech, Inc. et vice-président des sciences et affaires médicales mondiales chez The Medicines Co. Lance Baldo a obtenu un diplôme de premier cycle à l'Université Johns Hopkins et un doctorat à l'École de médecine de l'Université du Connecticut.
Anciens postes connus de Lance Baldo
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Chief Tech/Sci/R&D Officer | 25/03/2022 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/04/2019 |
| THE MEDICINES COMPANY | Corporate Officer/Principal | 01/02/2010 |
MedAptus, Inc.
 MedAptus, Inc. Information Technology ServicesTechnology Services MedAptus, Inc. operates as a healthcare information technology company which provides revenue cycle solutions to medical group practices and integrated delivery systems. It offers professional charge capture a flexible, scalable solution in use at single-specialty groups, multi-specialty clinics, academic centers and IDNs; technical charge capture eases and standardizes facility billing by automating the charge creation process across an outpatient care team; and infusion services charge capture which streamline and improve infusion coding by compliant capture. The company was founded by Lance Baldo and Malcolm M. Lloyd in 1999 and is headquartered in Boston, MA. | Founder | - |
Formation de Lance Baldo
| The Johns Hopkins University | Undergraduate Degree |
| The University of Connecticut School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Health Technology |
| Entreprise privées | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
MedAptus, Inc.
MedAptus, Inc. Information Technology ServicesTechnology Services MedAptus, Inc. operates as a healthcare information technology company which provides revenue cycle solutions to medical group practices and integrated delivery systems. It offers professional charge capture a flexible, scalable solution in use at single-specialty groups, multi-specialty clinics, academic centers and IDNs; technical charge capture eases and standardizes facility billing by automating the charge creation process across an outpatient care team; and infusion services charge capture which streamline and improve infusion coding by compliant capture. The company was founded by Lance Baldo and Malcolm M. Lloyd in 1999 and is headquartered in Boston, MA. | Technology Services |
